Redefining Drug Pipelines

 
Clinical Trails, Patents, and Intellectual Property in Cannabis and Psychedelics to Develop New Drug Substances
 
 
 

Join us for a conversation about novel drug substances! The topics range from clinical research to the forces within the cannabis industry’s patent and intellectual property issues. In this episode’s game, Dr. Marcu reads clues about cannabis news and political events, and participants have to guess the fake canna-news article. For the news segment, we discuss 18 psychedelics clinical trials that have received significant media attention, and whether they can possibly deliver on the hype. This episode's peer reviewed article is an analysis of the cannabis patent landscape and delves into how common practices may test the limits of the regulated market.

Episode’s Group:

Jahan Marcu, PhD (moderator)

Nigam B. Arora, PhD

Anna Symonds, MA

Today’s Game (2:00) :

Cannabis News Quiz

News and Popular Literature Links (11:20)

18 Clinical Trials That Could Make or Break the Future of the Psychedelics Industry


Rapid Fire Science Study Links (39:40):

High Risk, High Reward: Patent Law’s Effects on the Medical Marijuana Industry 

Credits:

Podcast audio engineering by Joe Leonardo, Cover art by Selina Lee, Intro music by Buddha by Kontekst, Transition music by K. LOUK. Outro music by Bensounds.

 
Previous
Previous

House of Serotonin

Next
Next

Agonize This!